BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23826789)

  • 1. Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.
    He ZF; Wu XA; Wang YP
    Scand J Infect Dis; 2013 Nov; 45(11):885-7. PubMed ID: 23826789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY; Huang JC; Shen MC; Chuang SH; Lee MH; Chen HC
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
    Uzun G; Onem Y; Hatipoglu M; Turhan V; Mutluoglu M; Ay H
    Scand J Infect Dis; 2013 Jan; 45(1):73-6. PubMed ID: 22746695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid-onset piperacillin-tazobactam induced thrombocytopenia.
    Shaik S; Kazi HA; Ender PT
    J Pharm Pract; 2015 Apr; 28(2):204-6. PubMed ID: 25609660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin induced bone marrow suppression: a case report.
    Kumar A; Choudhuri G; Aggarwal R
    BMC Clin Pharmacol; 2003 Jun; 3():2. PubMed ID: 12791166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible bone marrow depression by high-dose piperacillin/tazobactam.
    Ruiz-Irastorza G; Barreiro G; Aguirre C
    Br J Haematol; 1996 Dec; 95(4):611-2. PubMed ID: 8982034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenia caused by piperacillin/tazobactam.
    Pérez-Vázquez A; Pastor JM; Riancho JA
    Clin Infect Dis; 1998 Sep; 27(3):650-1. PubMed ID: 9770174
    [No Abstract]   [Full Text] [Related]  

  • 9. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis.
    Reichardt P; Handrick W; Linke A; Schille R; Kiess W
    Infection; 1999; 27(6):355-6. PubMed ID: 10624596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
    Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit.
    Bower M; Borders C; Schnure A; Groysman L; Tran MH
    World Neurosurg; 2018 Jun; 114():204-210. PubMed ID: 29555607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam treatment for severe intra-abdominal infections.
    Legrand JC; Bastin F; Belva P; Chastel C; Renaux J; Van Eukem P
    Acta Chir Belg; 1995; 95(3):162-5. PubMed ID: 7610751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction.
    Simons JP; Johnson JT; Yu VL; Vickers RM; Gooding WE; Myers EN; Pou AM; Wagner RL; Grandis JR
    Laryngoscope; 2001 Feb; 111(2):329-35. PubMed ID: 11210884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam-induced Sweet syndrome in a patient with chronic lymphocytic leukemia and autoimmune cholangitis.
    Cholongitas E; Pipili C; Dasenaki M; Kaklamanis L
    Am J Dermatopathol; 2008 Apr; 30(2):203-4. PubMed ID: 18360136
    [No Abstract]   [Full Text] [Related]  

  • 17. A puerperal patient with agranulocytosis during tazobactam / piperacillin administration : A case report.
    Iwazawa H; Tanaka H; Tatsumichi T; Yamaguchi K; Takahashi K; Suzuki K; Motoki T; Kanenishi K; Kosaka S
    J Med Invest; 2021; 68(3.4):368-371. PubMed ID: 34759160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report.
    Calogiuri GF; Nettis E; Di Leo E; Vacca A; Ferrannini A; Kounis NG
    Int J Cardiol; 2012 Mar; 155(3):e42-4. PubMed ID: 21839530
    [No Abstract]   [Full Text] [Related]  

  • 20. Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.
    Pournaras S; Ikonomidis A; Neou E; Kantzanou M; Maniatis AN; Tsakris A
    J Antimicrob Chemother; 2008 Mar; 61(3):757-8. PubMed ID: 18199562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.